The global secondary antibodies market is expected to grow at a CAGR of 5.5% during the forecast period, to reach USD 1.2 billion by 2030. The growth of this market is driven by the increasing demand for secondary antibodies in various applications such as ELISA (including many HIV tests), Western blot, immunostaining, immunohistochemistry, and immunocytochemistry.
The North American region is expected to dominate the global secondary antibodies market during the forecast period due to its high adoption rate of new technologies and innovations in healthcare sector. The Latin America region will also witness significant growth due to its rising awareness about diseases such as HIV/AIDS and cancer among people living in this region.
-The global market for secondary antibodies is expected to grow at a CAGR of 5.5% from 2017 to 2022.
-The global market for secondary antibodies is expected to grow at a CAGR of 5.5% from 2017 to 2022.-The growth in the global secondary antibody market can be attributed to the increasing demand for immunoassays and growing number of research and development activities in this field, which are driving the need for more sophisticated detection methods such as ELISA, Western blotting, immunohistochemistry, flow cytometry and others. -In addition, technological advancements have led to an increase in automation processes that has reduced labor costs associated with manual handling of samples during testing procedures; thereby reducing overall production costs while improving quality control standards.
Industry Growth Insights published a new data on “Secondary Antibodies Market”. The research report is titled “Secondary Antibodies Market research by Types (Men', Animals'), By Applications (ELISA (Including Many HIV Tests), Western Blot, Immunostaining, Immunohistochemistry, Immunocytochemistry), By Players/Companies Thermo Fisher Scientific (US), Jackson ImmunoResearch Laboratories (US), BD Biosciences (US), Santa Cruz Biotechnology (US), GE Healthcare (US), Sigma-Aldrich (US), Dako (US), LI-COR Biosciences (US), SouthernBiotech (US), Vector Laboratories (US), Bio-Rad (US), eBioscience (US), Cell Signaling Technology (US), Dianova (Germany), Abcam (UK), EMD Millipore (US), R&D Systems (US), Rockland Immunochemicals (US), Bethyl (US), Kirkegaard & Perry Laboratories (US), BioLegend (US), Abbexa (UK), Biorbyt (UK), Acris Antibodies (Germany), BioLogo (Germany), Sino Biological (China)”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Secondary Antibodies Market Research Report
By Type
Men', Animals'
By Application
ELISA (Including Many HIV Tests), Western Blot, Immunostaining, Immunohistochemistry, Immunocytochemistry
By Companies
Thermo Fisher Scientific (US), Jackson ImmunoResearch Laboratories (US), BD Biosciences (US), Santa Cruz Biotechnology (US), GE Healthcare (US), Sigma-Aldrich (US), Dako (US), LI-COR Biosciences (US), SouthernBiotech (US), Vector Laboratories (US), Bio-Rad (US), eBioscience (US), Cell Signaling Technology (US), Dianova (Germany), Abcam (UK), EMD Millipore (US), R&D Systems (US), Rockland Immunochemicals (US), Bethyl (US), Kirkegaard & Perry Laboratories (US), BioLegend (US), Abbexa (UK), Biorbyt (UK), Acris Antibodies (Germany), BioLogo (Germany), Sino Biological (China)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
237
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Secondary Antibodies Market Report Segments:
The global Secondary Antibodies market is segmented on the basis of:
Types
Men', Animals'
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
ELISA (Including Many HIV Tests), Western Blot, Immunostaining, Immunohistochemistry, Immunocytochemistry
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Thermo Fisher Scientific (US)
- Jackson ImmunoResearch Laboratories (US)
- BD Biosciences (US)
- Santa Cruz Biotechnology (US)
- GE Healthcare (US)
- Sigma-Aldrich (US)
- Dako (US)
- LI-COR Biosciences (US)
- SouthernBiotech (US)
- Vector Laboratories (US)
- Bio-Rad (US)
- eBioscience (US)
- Cell Signaling Technology (US)
- Dianova (Germany)
- Abcam (UK)
- EMD Millipore (US)
- R&D Systems (US)
- Rockland Immunochemicals (US)
- Bethyl (US)
- Kirkegaard & Perry Laboratories (US)
- BioLegend (US)
- Abbexa (UK)
- Biorbyt (UK)
- Acris Antibodies (Germany)
- BioLogo (Germany)
- Sino Biological (China)
Highlights of The Secondary Antibodies Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Men'
- Animals'
- By Application:
- ELISA (Including Many HIV Tests)
- Western Blot
- Immunostaining
- Immunohistochemistry
- Immunocytochemistry
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Secondary Antibodies Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Secondary antibodies are created in response to a primary antibody. Secondary antibodies are used to identify and bind specifically to specific antigens on the surface of cells or tissues.
Some of the major companies in the secondary antibodies market are Thermo Fisher Scientific (US), Jackson ImmunoResearch Laboratories (US), BD Biosciences (US), Santa Cruz Biotechnology (US), GE Healthcare (US), Sigma-Aldrich (US), Dako (US), LI-COR Biosciences (US), SouthernBiotech (US), Vector Laboratories (US), Bio-Rad (US), eBioscience (US), Cell Signaling Technology (US), Dianova (Germany), Abcam (UK), EMD Millipore (US), R&D Systems (US), Rockland Immunochemicals (US), Bethyl (US), Kirkegaard & Perry Laboratories (US), BioLegend (US), Abbexa (UK), Biorbyt (UK), Acris Antibodies (Germany), BioLogo (Germany), Sino Biological (China).
The secondary antibodies market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Secondary Antibodies Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Secondary Antibodies Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Secondary Antibodies Market - Supply Chain
4.5. Global Secondary Antibodies Market Forecast
4.5.1. Secondary Antibodies Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Secondary Antibodies Market Size (000 Units) and Y-o-Y Growth
4.5.3. Secondary Antibodies Market Absolute $ Opportunity
5. Global Secondary Antibodies Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Secondary Antibodies Market Size and Volume Forecast by Type
5.3.1. Men'
5.3.2. Animals'
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Secondary Antibodies Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Secondary Antibodies Market Size and Volume Forecast by Application
6.3.1. ELISA (Including Many HIV Tests)
6.3.2. Western Blot
6.3.3. Immunostaining
6.3.4. Immunohistochemistry
6.3.5. Immunocytochemistry
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Secondary Antibodies Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Secondary Antibodies Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Secondary Antibodies Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Secondary Antibodies Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Secondary Antibodies Demand Share Forecast, 2019-2026
9. North America Secondary Antibodies Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Secondary Antibodies Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Secondary Antibodies Market Size and Volume Forecast by Application
9.4.1. ELISA (Including Many HIV Tests)
9.4.2. Western Blot
9.4.3. Immunostaining
9.4.4. Immunohistochemistry
9.4.5. Immunocytochemistry
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Secondary Antibodies Market Size and Volume Forecast by Type
9.7.1. Men'
9.7.2. Animals'
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Secondary Antibodies Demand Share Forecast, 2019-2026
10. Latin America Secondary Antibodies Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Secondary Antibodies Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Secondary Antibodies Market Size and Volume Forecast by Application
10.4.1. ELISA (Including Many HIV Tests)
10.4.2. Western Blot
10.4.3. Immunostaining
10.4.4. Immunohistochemistry
10.4.5. Immunocytochemistry
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Secondary Antibodies Market Size and Volume Forecast by Type
10.7.1. Men'
10.7.2. Animals'
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Secondary Antibodies Demand Share Forecast, 2019-2026
11. Europe Secondary Antibodies Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Secondary Antibodies Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Secondary Antibodies Market Size and Volume Forecast by Application
11.4.1. ELISA (Including Many HIV Tests)
11.4.2. Western Blot
11.4.3. Immunostaining
11.4.4. Immunohistochemistry
11.4.5. Immunocytochemistry
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Secondary Antibodies Market Size and Volume Forecast by Type
11.7.1. Men'
11.7.2. Animals'
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Secondary Antibodies Demand Share, 2019-2026
12. Asia Pacific Secondary Antibodies Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Secondary Antibodies Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Secondary Antibodies Market Size and Volume Forecast by Application
12.4.1. ELISA (Including Many HIV Tests)
12.4.2. Western Blot
12.4.3. Immunostaining
12.4.4. Immunohistochemistry
12.4.5. Immunocytochemistry
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Secondary Antibodies Market Size and Volume Forecast by Type
12.7.1. Men'
12.7.2. Animals'
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Secondary Antibodies Demand Share, 2019-2026
13. Middle East & Africa Secondary Antibodies Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Secondary Antibodies Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Secondary Antibodies Market Size and Volume Forecast by Application
13.4.1. ELISA (Including Many HIV Tests)
13.4.2. Western Blot
13.4.3. Immunostaining
13.4.4. Immunohistochemistry
13.4.5. Immunocytochemistry
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Secondary Antibodies Market Size and Volume Forecast by Type
13.7.1. Men'
13.7.2. Animals'
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Secondary Antibodies Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Secondary Antibodies Market: Market Share Analysis
14.2. Secondary Antibodies Distributors and Customers
14.3. Secondary Antibodies Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Thermo Fisher Scientific (US)
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Jackson ImmunoResearch Laboratories (US)
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. BD Biosciences (US)
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Santa Cruz Biotechnology (US)
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. GE Healthcare (US)
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Sigma-Aldrich (US)
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Dako (US)
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. LI-COR Biosciences (US)
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. SouthernBiotech (US)
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Vector Laboratories (US)
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Bio-Rad (US)
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. eBioscience (US)
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Cell Signaling Technology (US)
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Dianova (Germany)
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Abcam (UK)
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. EMD Millipore (US)
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. R&D Systems (US)
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. Rockland Immunochemicals (US)
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. Bethyl (US)
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. Kirkegaard & Perry Laboratories (US)
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
